Discontinuation of antipsychotic medication is associated with an increased risk of relapse in patients with schizophrenia; however, critical pharmacokinetic and pharmacodynamic details of this association are not fully understood.
Discontinuation of antipsychotic medication is associated with an increased risk of relapse in patients with schizophrenia; however, critical pharmacokinetic and pharmacodynamic details of this association are not fully understood.